Sign in
Taking people in United StatesNo phase

Testing Diet and Supplements to Improve Muscle in Veterans With HIV and Obesity

Tests diet changes and supplements to improve muscle and reduce fat in Veterans with HIV.

Key facts

Who runs it
VA Office of Research and Development
Where
Nashville, United StatesSee the site
Trial code
Registry title
A Study to Improve Skeletal Muscle in Veterans With HIV
Status
Recruiting
People taking part
70 people, planned
Started
15 Jul 2025
Expected to end
30 Mar 2029
Type of study
Interventional, 4 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • w-3 fatty acid
  • L-carnitine
  • Control Diet
Record updated
26 June 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for male Veterans with HIV and excess body weight. The HIV must be well controlled by treatment.

Age
20 Years to 80 Years
Sex
Men only
Disease stage
Living with HIV, with a body mass index (BMI, weight compared to height) of 28-50 kg/m2.
Earlier treatment
Must have taken HIV medicine with an integrase strand transfer inhibitor for at least 3 months.
Biomarker or test result
HIV-1 RNA (amount of virus in the blood) below 50 copies/ml.

Main reasons for not taking part

  • Type 1 or type 2 diabetes, use of metformin or other diabetes drugs for pre-diabetes, or hemoglobin A1c above 6.5% (48 mmol/mol) at screening
  • Body weight gain or loss of more than 5% over the past 3 months
  • Stage 3 or worse kidney disease, or a diagnosed mitochondrial disorder
  • Inflammatory conditions, long-term corticosteroid use, or supplements that affect weight, muscle or immune function
  • Cannot have an MRI scan, cannot do physical tests, or cannot do an exercise test (for example heart strain during exercise or need for extra oxygen)

This trial only enrols participants living with HIV. The registry sentence this rests on: * Veteran * HIV+

The registry criteria, word for word

Show all 17 criteriaShow less

Who can take part

  • Veteran
  • HIV+
  • antiretroviral therapy = integrase strand transfer inhibitor for at least 3 months
  • HIV-1 RNA <50 copies/ml
  • age = 20 yrs
  • BMI 28-50 kg/m2

Who cannot take part

  • diagnosed mitochondrial disorder
  • diagnosed type 1 or type 2 diabetes
  • use of metformin or other anti-diabetic agents for pre-diabetes
  • inflammatory conditions or chronic corticosteroid use
  • stage 3 or greater kidney disease
  • hemoglobin A1c of >6.5% at screening visit
  • unstable body weight (gain or loss > 5% over past 3 months)
  • dietary or herbal supplements known to affect body weight, muscle mass, or immune function
  • MRI incompatibility
  • inability to perform physical function tests due to anatomical limitations
  • contradictions to CPET such as exercise-induced ischemia or supplemental oxygen

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 20 and 80 years old?

Where in United States

  • Tennessee Valley Healthcare System Nashville Campus, Nashville, TNNashville, United StatesContact: Patrick M LynchTaking people

About the trial

What the trial wants to find out

The Department of Veterans Affairs is the largest single provider of medical care to people with HIV in the United States. The condition of excess lipid within and around muscle, termed myosteatosis, predisposes Veterans to physical function decline, frailty, disability, and cardiometabolic diseases such as diabetes and cardiovascular disease. In the investigators current Merit supported cohort, the investigators found that 36% of Veterans with treated HIV and obesity have "myosteatotic type obesity". Based on the investigators findings, the investigators have designed a multipronged integrated intervention that combines: 1) dietary replacement of saturated with unsaturated fats; 2) administration of L-carnitine and omega-3 fatty acid supplementation; and 3) targeted resistance exercise training.

The 4 groups in the trial

  • Control DietPlacebo, for comparison

    Diet high in unsaturated fat

  • Diet + w-3 fatty acidsTreatment being tested

    Diet high in unsaturated fat plus omega-3 fatty acid supplement

    Treatment: w-3 fatty acid and Control Diet

  • Diet + L-CarnitineTreatment being tested

    Diet high in unsaturated fat plus L-carnitine supplement

    Treatment: L-carnitine and Control Diet

  • Diet + w-3 fatty acids + L-carnitineTreatment being tested

    Diet high in unsaturated fat plus omega-3 fatty acid supplement plus L-carnitine supplement

    Treatment: w-3 fatty acid, L-carnitine, and Control Diet

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Randomized Trial to Optimize Skeletal Muscle While Reducing Adiposity in Veterans With HIV
Plain-language title
Testing Diet and Supplements to Improve Muscle in Veterans With HIV and ObesityGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT06845046, who can take part
Record updated
26 June 2026